Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

<div>The Venn diagram shows 2,597 targets screened out from databases, which included 186 targets of the SZHP. The intersection indicates the 132 targets of the SZHP for dyslipidemia.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking 

Figure 3 | Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking 